Development of a Bicistronic Vector Driven by the Human Polypeptide Chain Elongation Factor 1α Promoter for Creation of Stable Mammalian Cell Lines That Express Very High Levels of Recombinant Proteins

This publication has 23 references indexed in Scilit:

• Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines
  British Journal of Cancer, 1998
• Location of the internal ribosome entry site in the 5' non-coding region of the immunoglobulin heavy-chain binding protein (BiP) mRNA: evidence for specific RNA-protein interactions
  Nucleic Acids Research, 1997
• IRES Bicistronic Expression Vectors for Efficient Creation of Stable Mammalian Cell Lines
  Biochemical and Biophysical Research Communications, 1996
• Bicistronic and Two-Gene Retroviral Vectors for UsingMDR1 as a Selectable Marker and a Therapeutic Gene
  Virology, 1996
• Bicistronic Vector for the Creation of Stable Mammalian Cell Lines that Predisposes All Antibiotic-Resistant Cells to Express Recombinant Protein
  BioTechniques, 1996
• Retroviral Coexpression of a Multidrug Resistance Gene (MDR1) and Humanα-Galactosidase A for Gene Therapy of Fabry Disease
  Human Gene Therapy, 1995
• The novel mechanism of initiation of picornavirus RNA translation
  Trends in Biochemical Sciences, 1990
• Cap-Independent Translation of Picornavirus RN As: Structure and Function of the Internal Ribosomal Entry Site
  Enzyme, 1990
• Use of the human elongation factor 1α promoter as a versatile and efficient expression system
  Gene, 1990
• Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.
  Proceedings of the National Academy of Sciences, 1989